PHILADELPHIA (November 30, 2021)—Suzanne M. Miller, PhD, a professor in the Cancer Prevention and Control Program at Fox Chase Cancer Center, has spearheaded a recent special edition of Translational Behavioral Medicine published today that summarizes several major lines of cancer prevention and control research and outlines future directions.
“This edition is a convergence of 50 years of the National Cancer Act and 10 years of the journal. The National Cancer Institute, part of the National Institutes of Health, and the journal came together to highlight where we are, how far we’ve come in terms of cancer prevention and control,” said Miller, who has been editor-in-chief of the journal since 2015.
The newest edition of Translational Behavioral Medicine: Practice, Policy, Research, “Cancer Prevention and Control for a New Decade,” features twelve articles that explore the current state of scientific progress in areas of cancer population sciences research.
“The articles focus on the authors’ perspectives on the future of research related to their area of expertise. The articles also co-address research related to two or more stages of the cancer control continuum, from etiology to prevention and detection, to diagnosis and treatment and survivorship, to end-of-life care,” said Miller.
“Our goal is to significantly impact the mission and vision of cancer prevention and control research, practice, and policy over the next decade. In doing so, this issue seeks to inspire and shepherd the next generation of scholars, highlighted by Translational Behavioral Medicine’s commitment that most articles include one or more early-career behavioral medicine scientist co-authors,” she said.
The special edition was developed as a result of collaborations among researchers from The Feinstein Institutes for Medical Research and the Division of Cancer Control and Population Sciences at the National Cancer Institute. The contributions in this special issue are divided into five subsections covering important topics such as impacts on population health, behavioral change strategies, and new methods for moving forward.
“When I came to the journal, there were virtually no cancer pieces in it. I made it my mission to make this a forum where cancer prevention and control researchers wanted to publish. This issue really culminates almost a decade of our becoming a leader in publishing great science that has an impact on population and policy,” said Miller.
“Cancer remains one of our greatest health concerns in the United States and around the world. We want to highlight that what the field needs right now, more than ever, is to continue its strong leadership and advocacy efforts to inform the agenda for U.S. cancer research and cancer policy going forward,” she said.
The Society of Behavioral Medicine is an organization of clinicians, educators, and researchers. It seeks to promote the study of the interactions of behavior with biology and the environment and apply that knowledge to improve the health and well-being of individuals, families, communities, and populations. Translational Behavioral Medicine is published by Oxford University Press on behalf of the Society for Behavioral Medicine